UA41916C2 - ПОХІДНІ 3,3a,4,5-ТЕТРАГІДРО-1Н-ОКСАЗОЛО[3,4-а]ХІНОЛІН-1-ОНУ, СПОСІБ ЇХ ОТРИМАННЯ, ЛІКАРСЬКИЙ ЗАСІБ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ - Google Patents
ПОХІДНІ 3,3a,4,5-ТЕТРАГІДРО-1Н-ОКСАЗОЛО[3,4-а]ХІНОЛІН-1-ОНУ, СПОСІБ ЇХ ОТРИМАННЯ, ЛІКАРСЬКИЙ ЗАСІБ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯInfo
- Publication number
- UA41916C2 UA41916C2 UA95094019A UA95094019A UA41916C2 UA 41916 C2 UA41916 C2 UA 41916C2 UA 95094019 A UA95094019 A UA 95094019A UA 95094019 A UA95094019 A UA 95094019A UA 41916 C2 UA41916 C2 UA 41916C2
- Authority
- UA
- Ukraine
- Prior art keywords
- hydrogen
- atom
- tetrahydro
- quinoline
- mao
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Quinoline Compounds (AREA)
Abstract
Похідні 3,3а,4,5-тетрагідро-1Н-оксазоло[3,4-а]хінолін-1-ону загальної формули (I) в якій n дорівнює 0 або 1; R1 - атом водню або етенил, метил, етил, фенил, гідроксиметил або метоксиметил; а також або R2 - метил, трифторметил або ціаногрупа, R3 - атом водню, гідроксил або бензилоксигрупа, а R4 і R5 - атоми водню; або R2 і R4 разом утворюють групу -(СН2)4-, R3 - гідроксил, а R5 - атом водню; або R2 і R5 разом утворюють групу -O-(СН2)3-, а R3 і R4 - атоми водню; або R2 і R5 разом утворюють групу -(СН2)4-, R3 - гідроксил, а R4 - атом водню, у вигляді ізомерів, включаючи енантіомери і діастереоізомери, і суміші вказаних різних форм, включаючи рацемічні суміші, що проявляють вибіркову інгібуючу здатність по відношенню до МАО-А, або змішану інгібуючу здатність по відношенню до МАО-А і МАО-В.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9410600A FR2724171B1 (fr) | 1994-09-05 | 1994-09-05 | Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
UA41916C2 true UA41916C2 (uk) | 2001-10-15 |
Family
ID=9466686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA95094019A UA41916C2 (uk) | 1994-09-05 | 1995-09-04 | ПОХІДНІ 3,3a,4,5-ТЕТРАГІДРО-1Н-ОКСАЗОЛО[3,4-а]ХІНОЛІН-1-ОНУ, СПОСІБ ЇХ ОТРИМАННЯ, ЛІКАРСЬКИЙ ЗАСІБ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ |
Country Status (28)
Country | Link |
---|---|
US (1) | US5641785A (uk) |
EP (1) | EP0699680B1 (uk) |
JP (1) | JP4225585B2 (uk) |
KR (1) | KR100392523B1 (uk) |
CN (1) | CN1055472C (uk) |
AT (1) | ATE190311T1 (uk) |
AU (1) | AU687591B2 (uk) |
CA (1) | CA2157427C (uk) |
CZ (1) | CZ286128B6 (uk) |
DE (1) | DE69515402T2 (uk) |
DK (1) | DK0699680T3 (uk) |
ES (1) | ES2145886T3 (uk) |
FI (1) | FI110945B (uk) |
FR (1) | FR2724171B1 (uk) |
GR (1) | GR3033554T3 (uk) |
HK (1) | HK1013652A1 (uk) |
HU (1) | HU218587B (uk) |
IL (1) | IL115276A (uk) |
NO (1) | NO306617B1 (uk) |
NZ (1) | NZ272920A (uk) |
PL (1) | PL184412B1 (uk) |
PT (1) | PT699680E (uk) |
RU (1) | RU2141482C1 (uk) |
SI (1) | SI0699680T1 (uk) |
SK (1) | SK281867B6 (uk) |
TW (1) | TW356467B (uk) |
UA (1) | UA41916C2 (uk) |
ZA (1) | ZA957414B (uk) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1078632A1 (en) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
US7553967B2 (en) * | 2004-03-12 | 2009-06-30 | Wyeth | 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
SG10201506994RA (en) * | 2007-03-09 | 2015-10-29 | Sanofi Aventis | Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
RU2366430C2 (ru) | 2007-05-23 | 2009-09-10 | Виктор Иванович Рощин | Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция |
AR078171A1 (es) | 2009-09-15 | 2011-10-19 | Sanofi Aventis | Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas |
CN105949120B (zh) * | 2016-05-27 | 2018-07-24 | 广东工业大学 | 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624861B1 (fr) * | 1987-12-21 | 1990-06-01 | Delalande Sa | Carbamates tricycliques, leur procede de preparation et leur application en therapeutique |
ES2013391A6 (es) * | 1989-02-08 | 1990-05-01 | Consejo Superior Investigacion | Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles. |
JPH04295470A (ja) * | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法 |
-
1994
- 1994-09-05 FR FR9410600A patent/FR2724171B1/fr not_active Expired - Lifetime
-
1995
- 1995-09-01 PT PT95401989T patent/PT699680E/pt unknown
- 1995-09-01 SI SI9530413T patent/SI0699680T1/xx unknown
- 1995-09-01 ES ES95401989T patent/ES2145886T3/es not_active Expired - Lifetime
- 1995-09-01 DK DK95401989T patent/DK0699680T3/da active
- 1995-09-01 EP EP95401989A patent/EP0699680B1/fr not_active Expired - Lifetime
- 1995-09-01 DE DE69515402T patent/DE69515402T2/de not_active Expired - Lifetime
- 1995-09-01 AT AT95401989T patent/ATE190311T1/de active
- 1995-09-01 CA CA2157427A patent/CA2157427C/en not_active Expired - Lifetime
- 1995-09-01 US US08/523,508 patent/US5641785A/en not_active Expired - Lifetime
- 1995-09-02 TW TW084109192A patent/TW356467B/zh not_active IP Right Cessation
- 1995-09-04 HU HU9502578A patent/HU218587B/hu unknown
- 1995-09-04 AU AU30415/95A patent/AU687591B2/en not_active Expired
- 1995-09-04 JP JP22646295A patent/JP4225585B2/ja not_active Expired - Lifetime
- 1995-09-04 KR KR1019950028714A patent/KR100392523B1/ko not_active IP Right Cessation
- 1995-09-04 FI FI954141A patent/FI110945B/fi not_active IP Right Cessation
- 1995-09-04 RU RU95114741A patent/RU2141482C1/ru active
- 1995-09-04 ZA ZA957414A patent/ZA957414B/xx unknown
- 1995-09-04 UA UA95094019A patent/UA41916C2/uk unknown
- 1995-09-04 NO NO953458A patent/NO306617B1/no not_active IP Right Cessation
- 1995-09-04 NZ NZ272920A patent/NZ272920A/en not_active IP Right Cessation
- 1995-09-04 CN CN95117143A patent/CN1055472C/zh not_active Expired - Lifetime
- 1995-09-04 CZ CZ19952262A patent/CZ286128B6/cs not_active IP Right Cessation
- 1995-09-04 SK SK1089-95A patent/SK281867B6/sk not_active IP Right Cessation
- 1995-09-04 PL PL95310273A patent/PL184412B1/pl unknown
- 1995-09-12 IL IL11527695A patent/IL115276A/en not_active IP Right Cessation
-
1998
- 1998-12-23 HK HK98114972A patent/HK1013652A1/xx not_active IP Right Cessation
-
2000
- 2000-05-31 GR GR20000401246T patent/GR3033554T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0000449A2 (hu) | N-szubsztituált dioxo-tiazolidil-benzamid-származékok és eljárás a vegyületek előállítására | |
DE3460325D1 (en) | N-phenyl-n'-cycloalkylalkanoylpiperazines and process for their preparation | |
CA2091562A1 (en) | Indole derivatives useful in psychotherapeutics | |
WO2002094275A8 (en) | Use of estrogen compounds to increase libido in women | |
CO4990941A1 (es) | Proceso para la sintesis de 1,3-dioles | |
AU4306796A (en) | Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs | |
HUP9900120A2 (hu) | Benzoszulfonszármazékok, eljárás előállításukra, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmény | |
MY102908A (en) | Isoxazole and furan derivatives, their preparation and use as antiviral agents. | |
NZ332608A (en) | alkyl 17-alpha-dichloroacetoxy-11- beta-hydroxy-androsta-1,4-diene-3-one-17-beta-carboxylates and medicaments | |
MY108909A (en) | Indole derivatives | |
MY111770A (en) | Short-acting dihydropyridines | |
IE43742L (en) | Ó15 -steroids | |
UA41916C2 (uk) | ПОХІДНІ 3,3a,4,5-ТЕТРАГІДРО-1Н-ОКСАЗОЛО[3,4-а]ХІНОЛІН-1-ОНУ, СПОСІБ ЇХ ОТРИМАННЯ, ЛІКАРСЬКИЙ ЗАСІБ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ | |
IL114833A0 (en) | Anthracyclinone derivatives their preparation and pharmaceutical compositions containing them | |
NZ336044A (en) | 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl benzoate derivatives, their preparation and therapeutic application | |
IL115184A0 (en) | Anthracycline derivatives their preparation and use | |
CA2241845A1 (en) | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity | |
HUP9601680A2 (hu) | Benzizotiazolil-szubsztituált amino-metil-krománok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és a vegyületek alkalmazása | |
MY129292A (en) | Antivirals | |
CA2007261A1 (en) | Novel tetralin derivatives | |
HUP0000783A2 (hu) | N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
AU1191597A (en) | Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors | |
HUT58065A (en) | Process for producing new 4'-epi-4'-aminoanthracyclines and pharmaceutical composiktions comprising same | |
EP0381508A3 (en) | Use of cinnamamide for relaxing muscle tone | |
MY105057A (en) | A process for preparing naphthalene derivatives |